Honasa Consumer Share Price Up 60% in 6 Months: Why the Mamaearth Parent Jumped Over 11% on the Q2 FY27 Update, What Is Behind the Rally, the Valuation and Brokerage Targets, and What Lies Ahead
- October 6, 2026
- Posted by: Kunal Singla
- Category: News
Honasa jumped 11%+ on 6 Oct. Q2 NSV growth seen in early thirties; margin early double digits. Up 61% in 6 months, 73% YTD. HDFC Sec Buy Rs 550. P/E about 64x.
Quick Answer
Honasa Consumer share price jumped over 11% intraday on 6 October, to roughly Rs 490 by my calculation from a Rs 478.55 early high that was 8.24% up, after the Mamaearth parent said its Q2 FY27 net sales value is expected to grow in the early thirties year on year with an early double-digit operating margin. That is ahead of HDFC Securities’ expectation of about 25% revenue growth and a 12% margin, and it extends a rally of more than 61% in six months and about 73% this year against a 7.75% fall in the Nifty 500. The drivers are a record Q1 FY27 profit of Rs 90.45 crore, Mamaearth growing in the high teens, The Derma Co crossing Rs 1,000 crore in annual sales and younger brands growing in the mid-forties, while HDFC Securities has a Buy with a Rs 550 target and the consensus is near Rs 557. At about 64 times trailing earnings and just below its 52-week high of Rs 509.80, the stock needs the Q2 results to confirm margins.
Honasa Consumer share price surged on Tuesday, 6 October, after the owner of Mamaearth, The Derma Co, Aqualogica and Dr. Sheth’s issued a provisional Q2 business update. The stock opened sharply higher, rose over 7% in the morning and later gained more than 11% intraday.
If you hold Honasa or are considering it, this article covers the Q2 FY27 business update and NSV growth, why the Honasa Consumer share price has risen about 60% in six months, the Q1 FY27 results and EBITDA, offline growth, brokerage views from HDFC Securities with its Rs 550 target, Jefferies, Emkay and CLSA, valuation near the 52-week high, risks and what lies ahead. Intraday numbers change, so recheck live prices.
Click Here – Get Free Investment Predictions
Honasa Consumer Share Price: Q2 FY27 Business Update
| Item | Management expectation for Q2 FY27 | Comparison |
|---|---|---|
| Net sales value growth | Early thirties percent year on year | HDFC Securities expected about 25% revenue growth |
| Mamaearth NSV growth | High teens percent | Accelerated from earlier quarters |
| Younger brands such as The Derma Co, Dr. Sheth’s and Aqualogica | Around mid-forties percent | Faster than the core brand |
| Operating margin | Early double digits, with a strong year-on-year improvement | HDFC Securities expected about 12% |
| Status of the numbers | Provisional and subject to final results | Results follow later |
The update is a trading update and not audited results, so margins and profit still have to be confirmed. The market read the early-thirties growth as a clear beat against estimates of about 25%, which lifted the Honasa Consumer share price.
Check the Univest Screener for live data on consumer stocks
Why Honasa Consumer Share Price Is Up 60% in Six Months
- Growth has accelerated, with Q1 FY27 revenue up 27% and Q2 NSV guided to the early thirties.
- Profitability has improved sharply, with Q1 EBITDA doubling to Rs 110 crore and margin rising to about 14%.
- Mamaearth, the largest brand, returned to high-teens growth after a weak patch.
- The Derma Co crossed Rs 1,000 crore in annualised sales and now has a face cleanser business above Rs 200 crore.
- Offline distribution is scaling, with offline about 35% of the business and more than 50% for Mamaearth, according to HDFC Securities.
- The stock was beaten down earlier, so a recovery in numbers drew investors.
The result is that the Honasa Consumer share price is up about 61% in six months and about 73% this year at the day’s high, against a 7.75% fall in the Nifty 500.
Honasa Consumer Q1 FY27 Results Behind the Honasa Consumer Share Price Rally
| Q1 FY27 metric | Figure | Comparison |
|---|---|---|
| Revenue from operations | Rs 755.94 crore | Up 27% from Rs 595.25 crore; up 15% on the quarter |
| EBITDA | Rs 110 crore | More than doubled; margin about 14% against 7.7% |
| Net profit | Rs 90.45 crore | Up 119% from Rs 41.32 crore; a record |
| Gross margin | About 70% | Stable |
| Brand highlights | Mamaearth high-teens growth; The Derma Co above Rs 1,000 crore annualised | Rosemary hair care range above Rs 100 crore |
The CFO has said that, adjusting for one-time items, the Q1 EBITDA margin was around 21% on a like-for-like basis and that Q2 usually sees a sequential dip as the summer season fades, which is why the early double-digit margin guidance for Q2 matters for the Honasa Consumer share price.
Download the Univest iOS App or Univest Android App to track the Honasa Consumer share price and consumer stocks live.
Honasa Consumer Share Price: Brokerage Targets and Upside
| Source | View | Target | Move from about Rs 490 |
|---|---|---|---|
| HDFC Securities | Buy, September 2027 target | Rs 550 | About +12% |
| Consensus of analysts | Average of analyst targets | About Rs 557, range Rs 390 to Rs 720 | About +14% |
| Jefferies and Emkay | Bullish after Q1 | Not quoted here | Not stated |
| CLSA | Hold | Not quoted here | Cautious on valuation |
The upside for the Honasa Consumer share price is my arithmetic from the Rs 490 level and may shift as the stock moves. The consensus range shows wide disagreement, from a low target of Rs 390 to a high of Rs 720.
Valuation and Levels for the Honasa Consumer Share Price
| Measure | Figure |
|---|---|
| Price on 6 October | About Rs 490 at the intraday high, up over 11% from about Rs 442 |
| 52-week range | Rs 248.40 to Rs 509.80 |
| Trailing P/E | About 62 times at Rs 472, and about 64 times at Rs 490 on EPS of Rs 7.63, my calculation |
| Market capitalisation | About Rs 15,000 crore to Rs 15,600 crore |
| Return in six months | More than 61% |
| Return this year | About 73% at the day’s high |
The stock is within about 4% of its 52-week high of Rs 509.80, so that level is the first resistance for the Honasa Consumer share price, and a rise above it would mean a fresh high. These are reference levels and not recommendations.
Risks Behind the Honasa Consumer Share Price Rally
Valuation: About 64 times earnings leaves little room for the Honasa Consumer share price if growth slows.
Provisional numbers: The Q2 update does not show profit, and margins can disappoint and hit the Honasa Consumer share price.
Seasonality: The CFO has flagged a sequential dip in Q2 margins.
Competition: Beauty and personal care has strong rivals and heavy marketing spend.
Mamaearth dependence: The largest brand’s recovery must hold for the Honasa Consumer share price to keep rising.
What Lies Ahead for the Honasa Consumer Share Price
- The full Q2 FY27 results, whose date is not confirmed here, for margins and profit.
- Whether Mamaearth sustains high-teens growth and The Derma Co keeps scaling.
- Offline expansion and modern trade offtake.
- Whether the stock clears its 52-week high of Rs 509.80 or falls back.
- Changes in brokerage targets after the update.
Conclusion
The Honasa Consumer share price jumped over 11% on 6 October after the Q2 FY27 update pointed to early-thirties NSV growth and an early double-digit margin, taking the rally to about 61% in six months. Record Q1 profit, Mamaearth’s recovery and The Derma Co’s scale support the story, but about 64 times earnings and provisional numbers mean the Q2 results must deliver. Consult a SEBI-registered advisor before making any decision.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Honasa Consumer share price jump on 6 October?
Ans. The Honasa Consumer share price rose over 11% after the company said Q2 FY27 net sales value should grow in the early thirties with an early double-digit margin.
What did Honasa say in its Q2 FY27 business update?
Ans. In its Q2 FY27 business update, net sales value is expected to grow in the early thirties, Mamaearth in the high teens and younger brands around the mid-forties, with provisional numbers.
How much has Honasa Consumer share price risen?
Ans. More than 61% in six months and about 73% this year at the day’s high, against a 7.75% fall in the Nifty 500.
What were Honasa’s Q1 FY27 results?
Ans. Before the Q2 FY27 NSV growth guidance, revenue rose 27% to Rs 755.94 crore, EBITDA more than doubled to Rs 110 crore and net profit rose 119% to a record Rs 90.45 crore.
What is the Honasa Consumer target price?
Ans. HDFC Securities has a Buy on the Honasa Consumer share price with a September 2027 target of Rs 550, and the consensus average is near Rs 557.
Is Honasa Consumer expensive?
Ans. At about 62 to 64 times trailing earnings, my calculation, the Honasa Consumer share price valuation is high and needs sustained growth.
What are the key risks?
Ans. High valuation, provisional Q2 numbers, a seasonal margin dip, competition and dependence on Mamaearth’s recovery.
Is Honasa Consumer a good stock to buy now?
Ans. This article does not constitute investment advice. The rally is strong but valuation is high. Consult a SEBI-registered financial advisor.
